Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Global Blood Ther (GBT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,497,734
  • Shares Outstanding, K 52,232
  • Annual Sales, $ 0 K
  • Annual Income, $ -117,020 K
  • 36-Month Beta 2.12
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 5.28

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate -0.88
  • Number of Estimates 10
  • High Estimate -0.72
  • Low Estimate -1.01
  • Prior Year -0.94
  • Growth Rate Est. (year over year) +6.38%

Price Performance

See More
Period Period Low Period High Performance
1-Month
34.92 +36.94%
on 12/24/18
48.93 -2.27%
on 01/18/19
+11.96 (+33.35%)
since 12/21/18
3-Month
30.15 +58.61%
on 11/30/18
50.11 -4.57%
on 12/03/18
+9.34 (+24.27%)
since 10/22/18
52-Week
30.15 +58.61%
on 11/30/18
68.05 -29.73%
on 02/21/18
-8.53 (-15.14%)
since 01/22/18

Most Recent Stories

More News
Interesting GBT Put And Call Options For February 15th

Investors in Global Blood Therapeutics Inc saw new options become available this week, for the February 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the GBT...

GBT : 47.82 (-2.15%)
GBT Announces New Employment Inducement Grants

Global Blood Therapeutics, Inc. (GBT or the Company) (NASDAQ: GBT) today announced that, on January 1, 2019, the compensation committee of the Company's board of directors granted three new employees options...

GBT : 47.82 (-2.15%)
GBT to Present at the 37th Annual J.P. Morgan Healthcare Conference

Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it will present at the 37 Annual J.P. Morgan Healthcare Conference on Tuesday, January 8, 2019, at 11:30 a.m. Pacific Time.

JPM : 102.94 (-1.58%)
GBT : 47.82 (-2.15%)
Global Blood The has the Best Relative Performance in the Biotechnology Industry (GBT , FOLD , IONS , AIMT , RDUS )

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the...

FOLD : 11.71 (-4.87%)
GBT : 47.82 (-2.15%)
IONS : 57.44 (-1.02%)
GBT Appoints Dawn Svoronos to Board of Directors

Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced the appointment of Dawn Svoronos to the company's board of directors. Ms. Svoronos has more than 30 years of experience in the biopharmaceutical...

GBT : 47.82 (-2.15%)
Global Blood Therapeutics, Voxelotor in Advanced Clinicals, Analysts Review and Target

NEW YORK, NY / ACCESSWIRE / December 10, 2018 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive...

GBT : 47.82 (-2.15%)
PIMCO Closed-End Funds Declare Special Year-End Distribution

The Board of Trustees/Directors of the PIMCO closed-end funds (each, a "Fund" and, collectively, the "Funds") has declared a special year-end distribution for certain Fund's common shares as summarized...

IPG : 21.65 (-2.70%)
NGVC : 15.75 (-2.42%)
STC : 43.17 (-0.99%)
ATUS : 18.73 (-1.78%)
RBA : 36.28 (+0.08%)
MHK : 126.72 (+0.08%)
NVCR : 46.62 (+0.37%)
CVSI : 4.6600 (+6.39%)
AC : 39.07 (-3.82%)
BSX : 37.26 (-1.14%)
HON : 139.82 (-1.43%)
POTND : 0.0200 (+32.45%)
PRTT : 1.2500 (-30.56%)
TARSD : 0.2033 (-1.64%)
NKE : 80.75 (+0.37%)
ROIC : 16.78 (-0.59%)
DGX : 86.18 (-0.99%)
EIX : 54.21 (-1.22%)
GARLF : 0.0850 (-2.19%)
MRNA : 15.56 (-6.77%)
MSPC : 0.0002 (unch)
RYAAY : 69.09 (+5.08%)
BA : 357.90 (-1.87%)
BDC : 50.92 (-3.69%)
BC : 48.99 (-2.68%)
OXFD : 14.46 (-2.82%)
NDAQ : 83.40 (+0.31%)
TTOO : 3.60 (-0.28%)
DMAC : 3.60 (-1.10%)
CMCM : 6.50 (-0.76%)
ALGN : 216.16 (-1.79%)
ABM : 35.23 (-2.08%)
RTN : 163.71 (-1.03%)
IESC : 17.02 (+0.71%)
KIDS : 34.06 (+0.06%)
CYL.VN : 0.175 (+12.90%)
FLIR : 44.73 (-1.45%)
NETC.CN : 0.140 (+7.69%)
SLCA : 13.36 (-3.95%)
BANX : 19.85 (+0.61%)
APOG : 33.82 (-1.26%)
RBBN : 5.53 (-2.47%)
SPLIF : 0.2100 (-0.43%)
SO : 47.07 (-0.32%)
SNWV : 0.2170 (-9.01%)
ACB : 6.19 (-3.88%)
CE : 95.73 (-2.13%)
QILFF : 0.1900 (-4.62%)
QILFD : 0.2331 (-29.98%)
MANH : 47.82 (-1.14%)
MKL : 1,035.00 (-3.11%)
HAL : 31.26 (-3.07%)
LZB : 29.68 (-1.49%)
INTC : 48.27 (-1.87%)
APHQF : 11.5700 (-3.05%)
AMZN : 1,632.17 (-3.77%)
ACHC : 28.32 (-2.31%)
TX : 28.26 (-2.18%)
SRPT : 120.28 (-2.05%)
JOUT : 63.52 (-4.95%)
CCAN : 0.2650 (+10.42%)
OBMP : 0.0103 (-6.36%)
ELY : 16.51 (-2.77%)
DY : 57.47 (-3.14%)
HIPH : 0.0530 (-5.19%)
POTN : 0.1058 (-0.94%)
JWN : 47.07 (-0.95%)
SYF : 26.55 (+1.03%)
AQUA : 10.04 (-4.02%)
NWVCF : 1.0517 (+0.16%)
USYNF : 3.1500 (+5.77%)
EMR : 63.01 (-1.05%)
BXE : 0.43 (-2.27%)
HSY : 108.31 (+0.16%)
EW : 168.29 (-0.07%)
SCQBD : 0.7420 (+1.08%)
PTS.TO : 13.11 (+0.15%)
PSX : 93.00 (-2.41%)
MVIS : 0.79 (-1.86%)
PCI : 22.27 (-1.63%)
PCN : 15.42 (+0.72%)
AVT : 41.25 (-2.92%)
MGNX : 11.53 (-6.34%)
ICBK : 18.21 (-4.26%)
DLR : 105.10 (-2.00%)
RHI : 59.76 (-1.82%)
YVR : 2.37 (-1.66%)
PTY : 16.08 (+0.63%)
PDI : 31.12 (-1.27%)
TNXP : 1.93 (-6.31%)
GBT : 47.82 (-2.15%)
QI.VN : 0.290 (-27.50%)
TSRO : 74.96 (+0.03%)
RHP : 76.42 (-0.31%)
NKTR : 44.76 (-3.12%)
GOOG : 1,070.52 (-2.53%)
JBLU : 17.37 (-1.31%)
IGC : 2.49 (unch)
WBT : 13.21 (-0.53%)
WRY.VN : 0.045 (+800.00%)
SAPIF : 28.6410 (-1.69%)
WSO : 144.38 (-0.99%)
LMT : 279.59 (-1.16%)
CMCSA : 34.97 (-3.42%)
HSDT : 7.65 (-8.16%)
GWRE : 84.94 (-0.90%)
CLGX : 36.05 (-1.39%)
FNSR : 21.21 (-2.35%)
SONS : 7.83 (+2.76%)
DEWM : 0.0010 (-9.09%)
SLG : 88.34 (-1.01%)
UPS : 102.68 (+1.06%)
PFN : 9.82 (+0.10%)
KMB : 115.23 (-1.40%)
ANZ.VN : 0.075 (+7.14%)
TAOP : 1.14 (-5.00%)
NSU : 4.48 (-0.88%)
CBDS : 3.5100 (+2.63%)
CTXS : 108.25 (-0.45%)
PCOM : 9.80 (-0.71%)
HTHT : 31.16 (-10.79%)
MAN : 73.13 (-1.76%)
CNK : 39.56 (-3.32%)
AMAT : 34.44 (-3.56%)
FMCC : 2.5100 (+5.46%)
MRK : 75.83 (-0.05%)
ATOS : 1.38 (+2.99%)
WTCRF : 0.0138 (unch)
MLRKF : 0.0835 (-6.07%)
GAZ-UN.VN : 0.600 (unch)
MEOH : 55.91 (-5.17%)
COOL : 17.33 (-0.69%)
SAVE : 58.06 (-2.19%)
PCRX : 40.46 (+1.05%)
RNLSY : 12.7650 (-1.47%)
COL : 141.04 (-0.42%)
COR : 93.21 (-1.15%)
IDXG : 1.03 (-4.63%)
MCD : 184.57 (+1.10%)
ETST : 0.8500 (+19.72%)
QNIIF : 0.7100 (-2.62%)
PII : 85.45 (-3.25%)
AMRS : 3.44 (-4.18%)
SON : 54.85 (+0.07%)
MCK : 125.87 (-0.63%)
APHA : 7.08 (+5.99%)
MCO : 155.48 (-2.46%)
GSKY : 11.00 (-0.09%)
LH : 135.70 (-1.45%)
SAP.TO : 38.67 (-1.60%)
ODFL : 132.90 (-2.73%)
NEU : 401.66 (+0.28%)
ORTX : 12.90 (-3.15%)
BXE.TO : 0.55 (-3.51%)
GWPRF : 11.8700 (+6.23%)
PZN : 8.49 (-3.41%)
RBX.VN : 0.075 (unch)
RNG : 88.78 (-2.71%)
SPG : 173.26 (-0.40%)
TRVN : 0.53 (-3.45%)
AMC : 13.51 (-6.57%)
UTX : 111.06 (-2.49%)
AMD : 19.76 (-4.86%)
NDLS : 7.45 (-1.46%)
MPWR : 120.98 (-3.04%)
KGKG : 0.0580 (+3.94%)
FRO-UN.VN : 0.550 (unch)
DMCAF : 0.2660 (-5.10%)
IRMTF : 11.9721 (-0.40%)
BOX : 19.45 (-2.16%)
IQST : 2.5000 (+25.00%)
ASPS : 23.23 (-2.72%)
HMNY : 0.01 (unch)
ROP : 274.70 (-2.60%)
GOVB : 14.5000 (unch)
PKO : 25.55 (-1.01%)
MYGN : 28.89 (-2.63%)
CRL : 117.59 (-1.36%)
GLPH : 0.0220 (-12.00%)
BXXRF : 0.0051 (-74.50%)
ADTN : 11.78 (-0.93%)
GRNH : 0.0200 (unch)
NS : 25.65 (-2.77%)
LTS : 2.99 (-3.55%)
INT : 23.97 (-1.36%)
INPX : 2.28 (+2.24%)
GSPT : 0.0600 (-50.00%)
MRO.VN : 0.110 (+10.00%)
COST : 212.40 (-0.56%)
EFX : 103.62 (-0.59%)
BMRN : 95.66 (-2.08%)
SPGI : 187.29 (-0.72%)
IGCC : 0.3940 (+3.41%)
PYPL : 89.94 (-1.29%)
LHSIF : 0.7526 (-0.97%)
TDY : 217.39 (-3.44%)
AZPN : 88.93 (-2.24%)
ENW.VN : 1.410 (+2.92%)
DMA.VN : 4.630 (-2.11%)
SNAP : 5.93 (-4.05%)
KSU : 108.45 (-1.87%)
MERC : 14.61 (-1.08%)
DVA : 56.85 (-0.91%)
UNI.VN : 3.700 (-0.27%)
MGI : 2.21 (+0.45%)
IGAP : 0.2310 (-57.92%)
FIT : 6.06 (+0.17%)
RAD : 0.94 (-3.51%)
LDSR : 0.0042 (+7.69%)
CYLYF : 0.1108 (+14.23%)
PMX : 11.38 (-1.04%)
ROBXF : 0.1851 (+262.94%)
BRO : 28.32 (-1.12%)
Global Blood Therapeutics Announces Proposed Public Offering of Common Stock

Global Blood Therapeutics, Inc. (GBT) (Nasdaq: GBT), a clinical-stage biopharmaceutical company determined to discover, develop and deliver innovative treatments that provide hope to underserved patient...

GBT : 47.82 (-2.15%)
GBT Announces New Employment Inducement Grants

Global Blood Therapeutics, Inc. (GBT or the Company) (NASDAQ: GBT) today announced that, on November 30, 2018, the compensation committee of the Company's board of directors granted six new employees options...

GBT : 47.82 (-2.15%)
Company News For Dec 4, 2018

Companies In The News Are: TSRO,GSK,TRCO,NXST,VNDA,GBT

GBT : 47.82 (-2.15%)
TSRO : 74.96 (+0.03%)
TRCO : 45.86 (+0.02%)
VNDA : 30.03 (-3.29%)
GSK : 38.97 (-0.23%)
NXST : 80.72 (-3.27%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade GBT with:

Business Summary

Global Blood Therapeutics, Inc. is a biopharmaceutical company which is engaged in discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. Its product candidate consists of GBT440 is an oral, once-daily prophylactic therapy for sickle cell disease which...

See More

Key Turning Points

2nd Resistance Point 49.83
1st Resistance Point 48.82
Last Price 47.82
1st Support Level 46.75
2nd Support Level 45.69

See More

52-Week High 68.05
Fibonacci 61.8% 53.57
Fibonacci 50% 49.10
Last Price 47.82
Fibonacci 38.2% 44.63
52-Week Low 30.15

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar